Future of Clinical Trials for Pulmonary Hypertension

被引：8
|
作者：
Rich, Stuart [1 ]
机构：
[1] Univ Chicago, Med Ctr, Cardiol Sect, Chicago, IL 60637 USA
来源：
CIRCULATION | 2011年 / 123卷 / 25期
关键词：
Editorial; clinical trials; hypertension; pulmonary; pulmonary heart disease; ARTERIAL-HYPERTENSION; THERAPY; PROSTACYCLIN; EPOPROSTENOL; SURVIVAL; PREVENTS; RATS;
D O I：
10.1161/CIRCULATIONAHA.111.037762
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2919 / 2921
页数：3
相关论文
共 50 条
  • [21] The new clinical trials on pharmacological treatment in pulmonary arterial hypertension
    Galiè, N
    Manes, A
    Branzi, A
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (04) : 1037 - 1049
  • [22] Clinical Trials for Pulmonary Hypertension in the Developing World Pulmonary Vascular Disease: The Global Perspective
    Sastry, Bhagavathula K. S.
    McGoon, Michael D.
    Gibbs, J. Simon R.
    CHEST, 2010, 137 (06) : 62S - 68S
  • [23] Does treatment response to ambrisentan vary by pulmonary arterial hypertension severity? Implications for clinicians and for the design of future clinical trials
    Chin, K. M.
    Bartolome, S.
    Miller, K.
    Blair, C.
    Gillies, H.
    Torres, F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (05) : 568 - 577
  • [24] Retrospective on global pulmonary hypertension clinical trials: 1999-2021
    Zheng, Lu
    Tan, Jun
    Yan, Yi
    Wang, Shang
    Yuan, Ping
    Wu, Cheng
    Zhao, Yin-Tao
    Yang, Hai-Bo
    Nappi, Francesco
    Tonelli, Adriano R.
    Wang, Lan
    Hu, Qing-Hua
    Jiang, Rong
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3372 - +
  • [25] Identification of novel biomarkers for use in clinical trials in BMPRII pulmonary hypertension
    Jones, Rowena
    Deliu, Nina
    Villar, Sofia
    Toshner, Mark
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Baseline Sex Differences in Pulmonary Arterial Hypertension Randomized Clinical Trials
    Ventetuolo, Corey E.
    Moutchia, Jude
    Baird, Grayson L.
    Appleby, Dina H.
    McClelland, Robyn L.
    Minhas, Jasleen
    Min, Jeff
    Holmes, John H.
    Urbanowicz, Ryan J.
    Al-Naamani, Nadine
    Kawut, Steven M.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2023, 20 (01) : 58 - 66
  • [27] Clinical trial design in phase 2 and 3 trials for pulmonary hypertension
    Nikkho, Sylvia
    Fernandes, Peter
    White, R. James
    Deng, Chunqin
    Farber, Harrison W.
    Corris, Paul A.
    PULMONARY CIRCULATION, 2020, 10 (04)
  • [28] Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials
    Humbert, Marc
    Singh, Manjit
    Furst, Daniel E.
    Khanna, Dinesh
    Seibold, James R.
    RHEUMATOLOGY, 2017, 56 : V33 - V37
  • [29] Patients' perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy
    Mai, Vicky
    Gosselin, Camille
    Tremblay, Elodie
    Rompre, Gabrielle
    Lajoie, Annie Christine
    Weatherald, Jason
    Lega, Jean-Christophe
    Bonnet, Sebastien
    Provencher, Steeve
    THORAX, 2023, 78 (07) : 721 - 725
  • [30] Do we need controlled clinical trials in pulmonary arterial hypertension?
    Galiè, N
    EUROPEAN RESPIRATORY JOURNAL, 2001, 17 (01) : 1 - 3
12345